Intravenous linezolid administered orally : A novel desensitization strategy
- Author
- CAWLEY, Michael J1 ; LIPKA, Ozana2
[1] Department of Pharmacy Practice and Pharmacy Administration, Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, United States
[2] Department of Pharmacy, Crozer Chester Medical Center, Upland, Pennsylvania, United States - Source
Pharmacotherapy. 2006, Vol 26, Num 4, pp 563-568, 6 p ; ref : 24 ref
- CODEN
- PHPYDQ
- ISSN
- 0277-0008
- Scientific domain
- Pharmacology drugs
- Publisher
- Pharmacotherapy, Boston, MA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- Enterococcus faecium bacteremia IgE desensitization hypersensitivity immunoglobulin E linezolid multidrug resistance myasthenia gravis oxazolidinone
- Keyword (fr)
- Antibactérien Antibiotique Anticancéreux Bactériémie Désensibilisation Enterococcus faecium Hypersensibilité IgE Linézolide Myasthénie Oxazolidinone dérivé Résistance multiple Résistance traitement Voie intraveineuse Voie orale Inhibiteur synthèse protéique Bactérie Bactériose Infection Micrococcales Neuromusculaire pathologie Oxazole dérivé Streptococcaceae Système nerveux pathologie
- Keyword (en)
- Antibacterial agent Antibiotic Antineoplastic agent Bacteremia Desensitization Enterococcus faecium Hypersensitivity IgE Linezolid Myasthenia gravis Oxazolidinone derivative Multiple resistance Treatment resistance Intravenous administration Oral administration Bacteria Bacteriosis Infection Micrococcales Neuromuscular diseases Oxazole derivatives Streptococcaceae Nervous system diseases
- Keyword (es)
- Antibacteriano Antibiótico Anticanceroso Bacteriemia Desensibilización Enterococcus faecium Hipersensibilidad IgE Linezolid Miastenia Oxazolidinona derivado Resistencia múltiple Resistencia tratamiento Vía intravenosa Vía oral Bacteria Bacteriosis Infección Micrococcales Neuromuscular patología Oxazol derivado Streptococcaceae Sistema nervioso patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05B Bacterial diseases / 002B05B02 Human bacterial diseases / 002B05B02M Bacterial sepsis
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17H Diseases of striated muscles. Neuromuscular diseases
- Discipline
- Infectious pathology Neurology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17651101
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1592/phco.26.4.563 
https://dx.doi.org/10.1592/phco.26.4.563
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1592\/phco.26.4.563\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:76:\"Intravenous linezolid administered orally : A novel desensitization strategy\";s:9:\"\u0000*\u0000jtitle\";s:15:\"Pharmacotherapy\";s:9:\"\u0000*\u0000stitle\";s:15:\"Pharmacotherapy\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"563\";s:8:\"\u0000*\u0000epage\";s:3:\"568\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-0008\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"CAWLEY\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:12:\"LIPKA, Ozana\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PHPYDQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:76:\"Intravenous linezolid administered orally : A novel desensitization strategy\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:15:\"Pharmacotherapy\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1592\/phco.26.4.563\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:76:\"Intravenous linezolid administered orally : A novel desensitization strategy\";s:9:\"\u0000*\u0000jtitle\";s:15:\"Pharmacotherapy\";s:9:\"\u0000*\u0000stitle\";s:15:\"Pharmacotherapy\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"563\";s:8:\"\u0000*\u0000epage\";s:3:\"568\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-0008\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"CAWLEY\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:12:\"LIPKA, Ozana\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PHPYDQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:76:\"Intravenous linezolid administered orally : A novel desensitization strategy\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:15:\"Pharmacotherapy\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1592\/phco.26.4.563\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1592\/phco.26.4.563\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:76:\"Intravenous linezolid administered orally : A novel desensitization strategy\";s:9:\"\u0000*\u0000jtitle\";s:15:\"Pharmacotherapy\";s:9:\"\u0000*\u0000stitle\";s:15:\"Pharmacotherapy\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"563\";s:8:\"\u0000*\u0000epage\";s:3:\"568\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-0008\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"CAWLEY\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:12:\"LIPKA, Ozana\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PHPYDQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:76:\"Intravenous linezolid administered orally : A novel desensitization strategy\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:15:\"Pharmacotherapy\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1592\/phco.26.4.563\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:76:\"Intravenous linezolid administered orally : A novel desensitization strategy\";s:9:\"\u0000*\u0000jtitle\";s:15:\"Pharmacotherapy\";s:9:\"\u0000*\u0000stitle\";s:15:\"Pharmacotherapy\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"563\";s:8:\"\u0000*\u0000epage\";s:3:\"568\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0277-0008\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"CAWLEY\";s:10:\"\u0000*\u0000aufirst\";s:9:\"Michael J\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:12:\"LIPKA, Ozana\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"PHPYDQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:76:\"Intravenous linezolid administered orally : A novel desensitization strategy\";s:8:\"\u0000*\u0000place\";s:10:\"Boston, MA\";s:6:\"\u0000*\u0000pub\";s:15:\"Pharmacotherapy\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"6\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
